Brad joined Aroa Biosurgery in November 2019. He has over 20 years of experience in the strategic sales and marketing of medical devices within the United States medical system and in other jurisdictions. Prior to Aroa Biosurgery, he served as Vice President, Sales at ACell Inc., a Columbia, Maryland based regenerative medicine company. Brad also has more than 15 years within both the Smith+Nephew and Johnson & Johnson families of companies, much of the time spent in senior global commercial roles. Brad has a proven record of accelerating revenue growth across multiple platforms including medical device, pharmaceutical, biologic, wound/tissue repair and regenerative medicine.
Brad holds a Master of Health Administration (Medical College of Virginia), a Bachelor of Arts in Economics with distinction (Virginia Military Institute) and has undertaken professional courses at Harvard Business School and The Wharton School, University of Pennsylvania. He is a long-standing member of the American College of Healthcare Executives.